Yes. I will not repeat what my colleagues already mentioned.
One thing is for sure. I will concur with Dr. Hurd that there are a number of networks in Canada and the U.S. Just in the field of addiction, for example, there are two very strong networks in the U.S. and in Canada that should be supported to conduct clinical trials.
The other piece of information and advice I would like to add is also the need for non-industry funded research. We've seen, of course, industry having a lot of money to put into that for [Technical difficulty—Editor] reasons. Collaboration with industry is important, but there is clearly a need for independently conducted research to provide the country and other countries with non-biased data surrounding the use of cannabis for a number of conditions.